Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hope for motherhood: study tests pausing breast cancer meds for pregnancy

NCT ID NCT02308085

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether young women with early-stage, hormone-sensitive breast cancer can temporarily stop their hormone therapy to try to get pregnant without raising their risk of cancer coming back. It involves 518 women aged 18 to 42 who have already been on hormone therapy for at least 18 months. The goal is to see if a pregnancy pause is safe and to track fertility and pregnancy outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

518 people

The number who actually took part.

Started

Dec 2014

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 42 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 and ≤ 42 years at enrollment. * Has received adjuvant endocrine therapy (SERM alone, GnRH analogue plus SERM or AI) for ≥18 months but ≤30 months for early breast cancer. Note: Patients who have received neo/adjuvant endocrine treatment within a clinical trial and patients who have received pharmaco-prevention are eligible. * The adjuvant endocrine therapy must have stopped within 1 month prior to enrollment. * Patient wishes to become pregnant. Note: Patients who have undergone oocyte/embryo/ovarian tissue cryopreservation at breast cancer diagnosis and/or have a previous history of assisted reproductive technology (ART) are eligible. * Breast cancer for which patient is receiving endocrine therapy must have been histologically-proven stage I-III, endocrine-responsive (i.e., estrogen and/or progesterone receptor positive, according to local definition of positive, determined using immunohistochemistry (IHC)), and treated with curative intent. Note: * Patients with synchronous bilateral invasive breast cancer (diagnosed histologically within 2 months) are eligible. * Patient with invasive breast cancer or synchronous bilateral invasive breast cancer (diagnosed histologically within 2 months) during pregnancy are eligible. * Patients with BRCA1/2 mutations are eligible. * Patients could have received neo/adjuvant chemotherapy, or other systemic therapy (e.g., neo/adjuvant HER2-targeted therapy) according to institutional policy and patient's desire. * Patient must be premenopausal at breast cancer diagnosis, as determined locally and documented in patient record. * Patient must be without clinical evidence of loco-regional and distant disease, as evaluated according to institutional assessment standards and documented in the patient record. * Written informed consent (IC) for trial participation must be signed and dated by the patient and the investigator prior to enrollment. * Written consent to biological material submission, indicating the patient has been informed of and agrees to tissue and blood material use, transfer and handling, must be signed and dated by the patient and the investigator prior to any procedures specific for this trial. * The patient has been informed of and agrees to data transfer and handling, in accordance with national data protection guidelines. * Patient must be accessible for follow-up. Exclusion Criteria: * Post-menopausal patients at BC diagnosis, as determined locally. * History of hysterectomy, bilateral oophorectomy or ovarian irradiation. * Patients with current local, loco-regional relapse and/or distant metastatic breast cancer. * Patients with a history of prior (ipsi- and/or contralateral) invasive BC. * Patients with previous or concomitant non-breast invasive malignancy. * Exceptions are limited exclusively to patients with the following previous malignancies, if adequately treated: basal or squamous cell carcinoma of the skin, in situ non-breast carcinoma, contra- or ipsilateral in situ breast carcinoma, stage Ia carcinoma of the cervix. * Concurrent disease or condition that would make the patient inappropriate for study participation or any serious medical disorder that would interfere with the patient's safety. * Patients with a history of noncompliance to medical treatments and/or considered potentially unreliable. * Patients with psychiatric, addictive, or any disorder that would prevent compliance with protocol requirements.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Early breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AO Universitaria Ospedale Di Circolo e Fondazione

    Varese, 21100, Italy

  • APHP, Tenon Hospital in Paris

    Paris, France

  • Abbott-Northwestern Hospital, 800 East 28th Street

    Minneapolis, Minnesota, 55407, United States

  • American University of Beirut Medical Center

    Beirut, Lebanon

  • Asan Medical Center

    Seoul, South Korea

  • Azienda Sanitaria di Bolzano

    Bolzano, 39100, Italy

  • Bon Secours Memorial Regional Medical Centre

    Mechanicsville, Virginia, 23116, United States

  • Bon Secours Saint Francis Medical Centre

    Midlothian, Virginia, 23114, United States

  • Bon Secours Saint Mary's Hospital

    Richmond, Virginia, 23223, United States

  • Bozeman Deaconess Hospital

    Bozeman, Montana, 59715, United States

  • Brust-Zentrum AG

    Zurich, 8008, Switzerland

  • Brustzentrum Thurgau - Obstetrics and Gynecology

    Frauenfeld, Switzerland

  • Brustzentum Kantonsspital St. Gallen

    Sankt Gallen, 9007, Switzerland

  • C.H.U. Sart-Tilman

    Liège, 4000, Belgium

  • CHA-Hopital Du St-Sacrement

    Québec, Quebec, G1S 4L8, Canada

  • CHCVs Hôpital de Sion - Service d'oncologie ambulatoire

    Sion, 736, Switzerland

  • CHUM - Centre Hospitalier de l'Universite de Montreal

    Montreal, Quebec, H2X 3E4, Canada

  • Carle Cancer Centre

    Urbana, Illinois, 61801, United States

  • Carle Physician Group - Effingham

    Effingham, Illinois, 62401, United States

  • Carle on Vermilion

    Danville, Illinois, 61832, United States

  • Case Western Reserve University

    Cleveland, Ohio, 44106, United States

  • Cedars Sinai Medical Centre

    Los Angeles, California, 90211, United States

  • Centre Hospitalier Universitaire de Sherbrooke

    Sherbrooke, Quebec, Canada

  • Centre Oscar Lambret

    Lille, 59020, France

  • Centro di Riferimento Oncologico

    Aviano, 33081, Italy

  • Chagrin Highlands

    Orange, Ohio, 44122, United States

  • Chaim Sheba Medical Center

    Tel Litwinsky, 5265601, Israel

  • Champalimaud Cancer Center - Breast Cancer Unit

    Lisbon, Portugal

  • Christiana Care Health System-Christiana Hospital

    Newark, Delaware, 19718, United States

  • Clinique St.Elizabeth

    Namur, 5000, Belgium

  • Cliniques Universitaires Saint-Luc

    Brussels, 1200, Belgium

  • Cliniques Universitaires Saint-Luc Brussels

    Brussels, Belgium

  • Complejo Hospitalario Universitario de Santiago

    Santiago de Compostela, Spain

  • Complejo Hospitalario de Navarra

    Pamplona, Spain

  • Dana Farber Cancer Institute

    Boston, Massachusetts, 02215-5450, United States

  • Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center

    Lebanon, New Hampshire, 03756, United States

  • Debrecen University Dep. of Oncology

    Debrecen, Hungary

  • Dickstein Cancer Treatment Centre

    White Plains, New York, 10601, United States

  • Doctor's Hospital of Laredo

    Laredo, Texas, 78045, United States

  • Emory University

    Atlanta, Georgia, 30322, United States

  • Emory University Hospital Midtown

    Atlanta, Georgia, 30308, United States

  • Essentia Health Cancer Center

    Duluth, Minnesota, 55805-1951, United States

  • Fairview Southdale Hospital

    Edina, Minnesota, 55435, United States

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington, 98109, United States

  • French Lyon Cancer Center

    Lyon, 69373, France

  • Galway University Hospital

    Galway, Ireland

  • Georgetown University Hospital

    Washington D.C., District of Columbia, 20007, United States

  • Greater Baltimore Medical Centre

    Baltimore, Maryland, 21204, United States

  • Greenville Health System Cancer Institute-Butternut

    Greenville, South Carolina, 29605, United States

  • Greenville Health System Cancer Institute-Eastside

    Greenville, South Carolina, 29611, United States

  • Greenville Health System Cancer Institute-Faris

    Greenville, South Carolina, 29605, United States

  • Greenville Health System Cancer Institute-Greer

    Greer, South Carolina, 29650, United States

  • Greenville Health System Cancer Institute-Seneca

    Seneca, South Carolina, 29672, United States

  • Greenville Health System Cancer Institute-Spartanburg

    Spartanburg, South Carolina, 29307, United States

  • Helen F. Graham Cancer Center

    Newark, Delaware, 19713, United States

  • Hennepin County Medical Center - Cancer Center

    Minneapolis, Minnesota, 55415, United States

  • Hospital Clinico San Carlos

    Madrid, Spain

  • Hospital Clinico Universitario Lozano Blesa

    Zaragoza, Spain

  • Hospital Clinico Universitario Virgen de la Arrixaca

    El Palmar, Murcia, Spain

  • Hospital Clinico Universitario Virgen de la Victoria

    Málaga, 29010, Spain

  • Hospital General Universitario de Valencia - Servico Oncologia

    Valencia, Spain

  • Hospital General de Catalunya

    Barcelona, Spain

  • Hospital Quiron Sagrado Corazon

    Seville, Spain

  • Hospital Son Espases, Palma de Mallorca

    Palma, Spain

  • Hospital Universitario Central de Asturias

    Oviedo, Spain

  • Hospital Universitario Donostia

    Donostia / San Sebastian, Spain

  • Hospital Universitario HM Sanchinarro - Centro Integral Oncologico Clara Campal (CIOCC)

    Madrid, 28050, Spain

  • Hospital Universitario Vall d'Hebron

    Barcelona, 08035, Spain

  • Hospital Universitario de Fuenlabrada

    Madrid, Spain

  • Hospital Virgen De La Salud

    Toledo, Spain

  • Huntsman Cancer Institute / University of Utah

    Salt Lake City, Utah, 84112, United States

  • IHA Hematology Consultants-Brighton

    Brighton, Michigan, 48114, United States

  • IHA Hematology Consultants-Canton

    Canton, Michigan, 48188, United States

  • IHA Hematology Consultants-Chelsea

    Chelsea, Michigan, 48118, United States

  • IHA Hematology Oncology Consultants-Ann Arbor

    Ypsilanti, Michigan, 48198, United States

  • Indiana University

    Indianapolis, Indiana, 46202, United States

  • Inselspital Bern

    Bern, Canton of Bern, 3010, Switzerland

  • Institut Bergonie

    Bordeaux, 33076, France

  • Institut Jules Bordet

    Brussels, Belgium

  • Institute of Oncology & Radiology of Serbia

    Belgrade, Serbia

  • Institute of Oncology Ljubljana - Medical Oncology Department

    Ljubljana, Slovenia

  • Instituto Catalán de Oncología de Gerona Hospital

    Girona, Spain

  • Istituto Europeo di Oncologia (IEO)

    Milan, 20141, Italy

  • Istituto Nazionale Ricerca Cancro

    Genova, Italy

  • Istituto Oncologico della Svizzera Italiana (IOSI)

    Bellinzona, Switzerland

  • Istituto scientifico Romagnolo per lo studio e la cura

    Meldola, Italy

  • John H Stroger Jr Hospital of Cook County

    Chicago, Illinois, 60612, United States

  • Johns Hopkins University

    Baltimore, Maryland, 21218, United States

  • Kamiiida Daiichi General Hospital

    Nagoya, 463-0802, Japan

  • Kansai Rosai Hospital

    Amagasaki, Hyōgo, 660-8511, Japan

  • Kantonspital Baden AG

    Baden, 5404, Switzerland

  • Kyoto University Hospital

    Kyoto, Japan

  • LKH Salzburg

    Salzburg, 5020, Austria

  • Laso General Hospital, First Department of Medical Oncology

    Athens, Greece

  • Leiden University Medical Centre, Albinusdreef 2, Postbus 9600

    Leiden, 2300 RC, Netherlands

  • Margaret R Pardee Memorial Hospital

    Hendersonville, North Carolina, United States

  • Mattoon Charleston Primary Care

    Mattoon, Illinois, 61938, United States

  • Mayo Clinic

    Rochester, Minnesota, 55902, United States

  • Med. Univ. Klinik f. Chir

    Vienna, 1090, Austria

  • Medical Oncology Hematology Consultants PA

    Newport, Delaware, 19713, United States

  • Mercy Hospital

    Coon Rapids, Minnesota, 55433, United States

  • Missouri Baptist Medical Center

    St Louis, Missouri, 63131, United States

  • Montefiore Medical Center - Einstein Campus, 1695 Eastchester Road

    The Bronx, New York, 10461, United States

  • Montefiore Medical Center - Moses Campus, 111 East 210th Street

    The Bronx, New York, 10467, United States

  • Montefiore Medical Center-Weiler Hospital

    The Bronx, New York, 10461, United States

  • Mount Sinai Hospital

    Toronto, Ontario, M5G 1X5, Canada

  • Multimedica Spa

    Castellanza, Vareze, Italy

  • NHO Kyushu Cancer Centre, 3-1-1 Notame Minami-ku Fukuoka-shi

    Fukuoka, 811-1395, Japan

  • NHO Osaka National Hospital

    Ōsaka, Japan

  • NHO Shikoku Cancer Center

    Matsuyama, Japan

  • National Cancer Center Hospital

    Tokyo, Japan

  • National Cancer Center for Global Medicine

    Tokyo, Japan

  • NorthShore Medical Centre

    Skokie, Illinois, 60076, United States

  • NorthShore University Health System - Glenbrook Hospital

    Glenview, Illinois, 60026, United States

  • NorthShore University HealthSystem-Evanston Hospital

    Evanston, Illinois, 60201, United States

  • NorthShore Unversity Health System - Highland Park Hospital

    Highland Park, Illinois, 60035, United States

  • Northwestern University

    Evanston, Illinois, 60201, United States

  • Norwegian Radium Hospital (Oslo University)

    Oslo, Norway

  • Odette Cancer Centre - Sunnybrook Health Sciences Centre

    Toronto, Ontario, Canada

  • Ohio State University

    Columbus, Ohio, 43210, United States

  • Okayama University Hospital

    Okayama, Japan

  • OnCare Hawaii Inc - POB I

    Honolulu, Hawaii, 96813, United States

  • OnCare Hawaii-Kuakini

    Honolulu, Hawaii, 96817, United States

  • Oncocare Bern

    Bern, 3012, Switzerland

  • Ospedale Belcolle di Viterbo

    Viterbo, Italy

  • Ospedale degli Infermi - S. C. Oncologia Medica

    Biella, Italy

  • Ospedale di Prato

    Prato, Firenze, Italy

  • Ospedale di Trento

    Trento, Trento, 38122, Italy

  • Park Nicollet Methodist Hospital

    Saint Louis Park, Minnesota, 55343, United States

  • Poudre Valley Hospital

    Fort Collins, Colorado, 80524, United States

  • Queen's Medical Centre

    Honolulu, Hawaii, 96813, United States

  • Regina Elena National Cancer Institute

    Rome, Italy

  • Regional Hematology Oncology Practice Associates

    Newport, Delaware, 19713, United States

  • Regions Hospital

    Saint Paul, Minnesota, 55101, United States

  • Rigshospitalet

    Copenhagen, 2100, Denmark

  • Rocky Mountain Cancer Center

    Boulder, Colorado, 80303, United States

  • SCL Health Saint Joseph Hospital

    Denver, Colorado, 80218, United States

  • SUNY Upstate Medical University

    Syracuse, New York, 13210, United States

  • Saint Joseph Mercy Hospital

    Ann Arbor, Michigan, 48103, United States

  • Saint Joseph Mercy Hospital - Brighton

    Brighton, Michigan, 48114, United States

  • Saint Joseph Mercy Hospital - Chelsea

    Chelsea, Michigan, 48118, United States

  • Saint Joseph Mercy Hospital- Canton

    Canton, Michigan, 48188, United States

  • Salvatore Maugeri Foundation - Medical Oncology Unit

    Pavia, 27100, Italy

  • Samsung Medical Center

    Seoul, 06351, South Korea

  • Sanford Bismark Medical Centre

    Bismarck, North Dakota, 58501, United States

  • Sanford Cancer Centre Oncology Clinic

    Sioux Falls, South Dakota, 57104, United States

  • Sanford Clinic North - Bemidji

    Bemidji, Minnesota, 56501, United States

  • Sanford Medical Centre

    Fargo, North Dakota, 58122, United States

  • Sanford Roger Maris Cancer Centre

    Fargo, North Dakota, 58102, United States

  • Sanford USD Medical Centre - Sioux Falls

    Sioux Falls, South Dakota, 57104, United States

  • Seattle Cancer Care Alliance

    Seattle, Washington, 98109, United States

  • Seirei Hamamatsu General Hospital

    Hamamatsu, Shizuoka, Japan

  • Seoul National University Hospital

    Seoul, South Korea

  • Shaare Zedek Medical Center

    Jerusalem, Israel

  • Sharp Memorial Hospital

    San Diego, California, United States

  • Showa University Hospital

    Tokyo, Japan

  • Sibley Memorial Hospital

    Washington D.C., District of Columbia, 20016, United States

  • Smilow Cancer Hospital Care Center at Saint Francis

    Hartford, Connecticut, 06105, United States

  • Smilow Cancer Hospital Care Center-Fairfield

    Fairfield, Connecticut, 06824, United States

  • Smilow Cancer Hospital Care Center-Trumbull

    Trumbull, Connecticut, 06611, United States

  • Smilow Cancer Hospital-Derby Care Center

    Derby, Connecticut, 06418, United States

  • Smilow Cancer Hospital-Orange Care Center

    Orange, Connecticut, 06477, United States

  • Smilow Cancer Hospital-Torrington Care Center

    Torrington, Connecticut, 06790, United States

  • Smilow Cancer Hospital-Waterbury Care Center

    Waterbury, Connecticut, 06708, United States

  • Social Medical Corporation Hakuaikai Sagara Hospital

    Kagoshima, Japan

  • Southeastern Medical Oncology Centre

    Clinton, North Carolina, 28328, United States

  • Southeastern Medical Oncology Centre

    Goldsboro, North Carolina, 27534, United States

  • Southeastern Medical Oncology Centre

    Jacksonville, North Carolina, 28546, United States

  • Southeastern Medical Oncology Centre

    Wilson, North Carolina, 27534, United States

  • Spartanburg Medical Center

    Spartanburg, South Carolina, 29303, United States

  • Spital STS AG Onkologiezentrum Thun-Berner Oberland

    Thun, Canton of Bern, 3600, Switzerland

  • St John of God Subiaco Hospital

    Perth, Western Australia, 6008, Australia

  • St John's Hospital

    Maplewood, Minnesota, 55109, United States

  • St Luke's International Hospital

    Tokyo, Japan

  • St Marianna University School of Medicine Hospital

    Kawasaki, Japan

  • St Michael's Hospital

    Toronto, Ontario, M5B 1W8, Canada

  • St Vincent's University Hospital

    Dublin, Ireland

  • St. James's Hospital

    Dublin, Ireland

  • Stanford Cancer Institute

    Palo Alto, California, 94305, United States

  • Straub Clinic and Hospital

    Honolulu, Hawaii, 96701, United States

  • The Cancer Institute Hospital of JFCR

    Tokyo, Japan

  • The Carle Foundation Hospital

    Urbana, Illinois, 61801, United States

  • Tohoku University Hospital

    Sendai, Japan

  • Tom Baker Cancer Centre

    Calgary, Alberta, T2N 4N2, Canada

  • Toranomon Hospital

    Minato-ku, Tokyo, 105-8470, Japan

  • U.O Medicina Oncologica Ospedale di Carpi

    Carpi, Modena, 41012, Italy

  • UNC Lineberger Comprehensive Cancer Center

    Chapel Hill, North Carolina, 27599, United States

  • UO Oncologia, Rimini Hospital

    Rimini, 47923, Italy

  • UPMC-Magee Womens Hospital

    Pittsburgh, Pennsylvania, 15213, United States

  • UZ Leuven

    Leuven, 3000, Belgium

  • Univ. Klinik f. Frauenheilkunde Innsbruck

    Innsbruck, 6020, Austria

  • Univ. Klinik f. Frauenheilkunde u. Geburtshilfe

    Graz, 8036, Austria

  • Universitario Virgen del Rocio

    Seville, 41013, Spain

  • University General Hospital of Heraklion

    Stavrakia, Crete, 71110, Greece

  • University Hospital Geneva

    Geneva, 1211, Switzerland

  • University Hospital Limerick

    Limerick, Ireland

  • University Hospital Waterford

    Waterford, Ireland

  • University Hospital Zurich

    Zurich, 8091, Switzerland

  • University Hospital of Lausanne (CHUV) BH06 - Oncology Department

    Lausanne, Switzerland

  • University of Colorado Cancer Centre - Anschutz Cancer Pavilion

    Aurora, Colorado, 80045, United States

  • University of Eastern Piedmont

    Novara, 28100, Italy

  • University of New Mexico Cancer Center

    Albuquerque, New Mexico, 87131, United States

  • University of Tsukuba

    Tsukuba, Japan

  • University of Vermont Medical Centre

    Burlington, Vermont, 05401, United States

  • University of Washington Medical Center

    Seattle, Washington, 98195, United States

  • Universitätsspital Basel

    Basel, 4031, Switzerland

  • Vancouver Cancer Centre

    Vancouver, British Columbia, V5Z 1M9, Canada

  • Weill Medical College of Cornell University

    New York, New York, 10065, United States

  • Women and Infants Hospital of Rhode Island

    Providence, Rhode Island, 02905, United States

  • Yale University - Yale Cancer Centre

    New Haven, Connecticut, 06520, United States

  • Yale-New Haven Hospital North Haven Medical Center

    North Haven, Connecticut, 06473, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.